CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Supernus Pharmaceuticals Inc  (SUPN)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Supernus Pharmaceuticals Inc's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Total Assets Change 65.71 % 64.12 % 71.1 % 41.81 % 39.27 %
Y / Y Net Income Change 113.41 % 110.57 % 1478.8 % 411.27 % 426.17 %
Return On Assets (TTM) 34.06 % 36.21 % 37.75 % 13.43 % 9.97 %
Total Ranking # 96 # 91 # 83 # 327 # 408
Seq. Total Assets Change 4.1 % 8.58 % 30.41 % 12.42 % 3.1 %
Seq. Net Income Change -28.09 % -76.84 % 503.12 % 112.46 % -29.04 %


Roa Comment
Supernus Pharmaceuticals Inc yielded Return on Asset in I. Quarter above company average, at 34.06 %.

ROA decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 21 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 91 to 96.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 22
S&P 500 # 94

Return On Assets Statistics
High Average Low
37.75 %
21.96 %
7.49 %
(Sep 30 2016)   (Sep 30 2015)


You need to upgrade your Flash Player
Financial Statements
Supernus Pharmaceuticals Inc's Equity $ 206 Millions SUPN's Balance sheet
Supernus Pharmaceuticals Inc's Income $ 10 Millions Quarterly SUPN's Income Statement
SUPN's Income by Division See SUPN's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SUPN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for SUPN's Competitors
Roa for Supernus Pharmaceuticals Inc's Suppliers
Return On Asstes for SUPN's Customers

You may also want to know
SUPN's Roi SUPN's Inventory Turnover Ratio SUPN's Growth Rates SUPN's Dividend Comparisons
SUPN's Annual Roi SUPN's Profitability Ratios SUPN's Asset Turnover Ratio SUPN's Dividend Growth
SUPN's Roe SUPN's Valuation Ratios SUPN's Financial Strength Ratios SUPN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %
Apricus Biosciences, Inc.  61.49 %
Biotime Inc  59.79 %
Eagle Pharmaceuticals, Inc.  57.27 %
First Choice Healthcare Solutions, Inc.  43.68 %
Masimo Corp  43.32 %
Opiant Pharmaceuticals, Inc.  38.01 %
Pro Dex Inc  34.06 %
Supernus Pharmaceuticals Inc  34.06 %
Psychemedics Corp  32.74 %
Enzo Biochem Inc  30.82 %
United Therapeutics Corp  28.08 %
Fonar Corporation  27.43 %
Biotelemetry, Inc.  27.40 %
Regenicin, Inc.  23.99 %
Petmed Express Inc  23.42 %
Gilead Sciences Inc  21.83 %
China Biologic Products, Inc.  20.68 %
Alpha Pro Tech Ltd  20.13 %
Zynex Inc  19.88 %
Titan Pharmaceuticals Inc  19.74 %
Mettler Toledo International Inc  19.42 %
National Research Corporation  19.02 %
Corcept Therapeutics Inc  19.02 %
Innoviva, Inc.  18.94 %
Biospecifics Technologies Corp  18.71 %
Oramed Pharmaceuticals Inc.  17.61 %
Atrion Corp  16.90 %
China Longyi Group International Holdings Ltd  16.76 %



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com